Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
Toxicologic Pathology
This Article
Right arrow Free Full Text (Free PDF) Free
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Molon-Noblot, S.
Right arrow Articles by Van Zwieten, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Molon-Noblot, S.
Right arrow Articles by Van Zwieten, M. J.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Journal Article

Effect of Chronic Growth Hormone Administration on Skeletal Muscle in Dogs

Sylvain Molon-Noblot

Merck Sharp & Dolime-Chibret Laboratories, Research Center, Department of Safety Assessment, BP 134, Route de Marsat, 63203 Riom, France

Philippe Laroque

Merck Sharp & Dolime-Chibret Laboratories, Research Center, Department of Safety Assessment, BP 134, Route de Marsat, 63203 Riom, France

Srinivasa Prahalada

Merck Research Laboratories, Department of Safety Assessment, West Point, Pennsylvania 19486, USA

Lea G. Stabinski

Merck Research Laboratories, Department of Safety Assessment, West Point, Pennsylvania 19486, USA

Chao-Min Hoe

Merck Research Laboratories, Department of Biometrics, West Point, Pennsylvania 19486, USA

Chennekatu P. Peter

Merck Research Laboratories, Department of Safety Assessment, West Point, Pennsylvania 19486, USA

Pierre Duprat

Merck Sharp & Dolime-Chibret Laboratories, Research Center, Department of Safety Assessment, BP 134, Route de Marsat, 63203 Riom, France

Matthew J. Van Zwieten

Merck Research Laboratories, Department of Safety Assessment, West Point, Pennsylvania 19486, USA

Administration of growth hormone (GH) results in increased body weight gain in dogs. Increased body weight gain is believed to be a result of the trophic effect of GH on the musculoskeletal system. However, edema is one of the side effects described in man following exogenous GH administration. Thus, the objective of this study was to determine if the expected increased weight gain in GH-treated dogs is a result of increased muscle mass. Porcine growth hormone (pGH), administered subcutaneously to beagle dogs at doses of 0.025, 0.1, and 1 IU/kg/day for 14 wk, resulted in elevated serum GH and insulin-like growth factor-1 (IGF-1) levels (see accompanying paper, Prahalada et al). This was associated with a significant increase in body weight gain and weights of the cranial tibialis muscle in both male and female dogs. The increased muscle mass likely contributed to the significant increase in body weight gain seen in both sexes. Quantitative analysis of skeletal muscle sections stained for ATPase activity showed increases in type I (slow twitch) and type II (fast twitch) myofiber sizes in mid- and high-dose males and in high-dose females. The ratio of type I and type II muscle fibers remained unchanged. Hypertrophic myofibers were enlarged but had a normal histologic and ultrastructural organization when observed by light and transmission electron microscopy. The results of this study have demonstrated that increased muscle mass in pGH-treated dogs is related to hypertrophy of muscle fibers and not due to edema. Exogenous GH administration has an anabolic effect on skeletal muscle in dogs.

Key Words: Muscle hypertrophy • experimental • pharmacological effect • morphometry • electron microscopy

Toxicologic Pathology, Vol. 26, No. 2, 207-212 (1998)
DOI: 10.1177/019262339802600203


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
J ANIM SCIHome page
R. Draghia-Akli, K. K. Cummings, A. S. Khan, P. A. Brown, and R. H. Carpenter
Effects of plasmid-mediated growth hormone releasing hormone supplementation in young, healthy Beagle dogs
J Anim Sci, September 1, 2003; 81(9): 2301 - 2310.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
S. Molon-Noblot, P. Laroque, S. Prahalada, L. G. Stabinski, C. P. Peter, P. Duprat, and M. J. Van Zwieten
Morphological Changes in the Kidney of Dogs Chronically Exposed to Exogenous Growth Hormone
Toxicol Pathol, July 1, 2000; 28(4): 510 - 517.
[Abstract] [PDF]


Home page
Toxicol PatholHome page
S. Prahalada, L. G. Stabinski, H. Y. Chen, R. E. Morrissey, G. De Burlet, D. Holder, D. H. Patrick, C. P. Peter, and M. J. van Zwieten
Pharmacological and Toxicological Effects of Chronic Porcine Growth Hormone Administration in Dogs
Toxicol Pathol, March 1, 1998; 26(2): 185 - 200.
[Abstract] [PDF]


Home page
Toxicol PatholHome page
C. A. Bondy
Growth Hormone Augmentation--A New Era?
Toxicol Pathol, March 1, 1998; 26(2): 213 - 216.
[PDF]